Founder SVA retrotransposal insertion in Fukuyama-type congenital muscular dystrophy and its origin in Japanese and Northeast Asian populations

American Journal of Medical Genetics

Volumn 138 A, Issue 4, 2005, Pages 344-348

  Watanabe, Masashi ^a   Kobayashi, Kazuhiro ^b   Jin, Feng ^c   Park, Kyung Sook ^d   Yamada, Takatsugu ^a   Tokunaga, Katsushi ^e   Toda, Tatsushi ^b  

^a AZABU UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^d Sungshin Women's University   (South Korea)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Fukutin; Fukuyama type congenital muscular dystrophy (FCMD); Genetic epidemiology; Japanese; Northeast Asia; Retrotransposon; SINE VNTR Alu (SVA)

Indexed keywords

FUKUTIN;

3' UNTRANSLATED REGION; ALLELE; ALU SEQUENCE; ARTICLE; ASIA; AUTOSOMAL RECESSIVE DISORDER; BRAIN MALFORMATION; CHINESE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DNA DETERMINATION; FOUNDER EFFECT; FUKUTIN GENE; FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; GENE; GENE INSERTION; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; IMMIGRATION; JAPAN; KOREA; MAJOR CLINICAL STUDY; MONGOLIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROPOSON; SEQUENCE ANALYSIS; VARIABLE NUMBER OF TANDEM REPEAT;

ASIA; BASE SEQUENCE; DNA PRIMERS; FOUNDER EFFECT; GENETICS, POPULATION; HUMANS; JAPAN; MUSCULAR DYSTROPHIES; POLYMERASE CHAIN REACTION; RETROELEMENTS;

EID: 27444436452     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.30978     Document Type: Article

References (29)

1. Aravind L, Koonin EV. 1999. The fukutin protein family - Predicted enzymes modifying cell-surface molecules. Curr Biol 9:R836-R837.
2. Bannai M, Ohashi J, Hanihara S, Takahashi Y, Juji T, Omoto K, Tokunaga K. 2000. Analysis of HLA genes and haplotypes in Ainu (from Hokkaido, northern Japan) supports the premise that they descent from Upper Paleolithic populations of East Asia. Tissue Antigens 55:128-139.
3. Beltrán-Valero de Bernabé D, Currier S, Steinbrecher A, Celli J, van Beusekom E, van der Zwaag B, Kayserili H, Merlini L, Chitayat D, Dobyns WB, Cormand B, Lehesjoki AE, Cruces J, Voit T, Walsh CA, van Bokhoven H, Brunner HG. 2002. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 71:1033-1043.
4. Beltrán-Valero de Bernabé D, van Bokhoven H, van Beusekom E, van den Akker W, Kant S, Dobyns WB, Cormand B, Currier S, Hamel B, Talim B, Topaloglu H, Brunner HG. 2003. A homozygous nonsense mutation in the fukutin gene causes a Walker-Warburg syndrome phenotype. J Med Genet 40:845-848.
5. Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, Pointing CP, Estournet B, Romero NB, Mercuri E, Voit T, Sewry CA, Guicheney P, Muntoni F. 2001. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan. Am J Hum Genet 69:1198-1209.
6. Colombo R, Bignamini AA, Carobene A, Sasaki J, Tachikawa M, Kobayashi K, Toda T. 2000. Age and origin of the FCMD 3′-untranslated-region retrotransposal insertion mutation causing Fukuyama-type congenital muscular dystrophy in the Japanese population. Hum Genet 107:559-567.
7. Eberhart DE, Curran T. 1998. Yayoi era mutation disrupts brain and muscle. Nat Med 4:1002-1003.
8. Fukuyama Y, Ohsawa M. 1984. A genetic study of the Fukuyama type congenital muscular dystrophy. Brain Dev 6:373-390.
9. Fukuyama Y, Kawazura M, Haruna H. 1960. A peculiar form of congenital progressive muscular dystrophy. Report of fifteen cases. Pediatr Univ Tokyo 4:5-8.
10. Fukuyama Y, Ohsawa M, Suzuki H. 1981. Congenital muscular dystrophy of the Fukuyama type-Clinical, genetic, and pathological considerations. Brain Dev 3:1-29.
11. Grewal PK, Holzfeind PJ, Bittner RE, Hewitt JE. 2001. Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse. Nat Genet 28:151-154.
12. Hanihara K. 1991. Dual structure model for the population history of the Japanese. Jpn Rev 2:1-33.
13. Hayashi YK, Ogawa M, Tagawa K, Noguchi S, Ishihara T, Nonaka I, Arahata K. 2001. Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 57:115-121.
14. Kato R, Kawamura J, Sugawara H, Niikawa N, Matsumoto N. 2004. A rapid diagnostic method for a retrotransposal insertional mutation into the FCMD gene in Japanese patients with Fukuyama congenital muscular dystrophy. Am J Med Genet 127:54-57.
15. Kobayashi K, Nakahori Y, Miyake M, Matsumura K, Kondo-Iida E, Nomura Y, Segawa M, Yoshioka M, Saito K, Osawa M, Hamano K, Sakakihara Y, Nonaka I, Nakagome Y, Kanazawa I, Nakamura Y, Tokunaga K, Toda T. 1998a. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394:388-392.
16. Kobayashi K, Nakahori Y, Mizuno K, Miyake M, Kumagai Y, Honma A, Nonaka I, Nakamura Y, Tokunaga K, Toda T. 1998b. Founder-haplotype analysis in Fukuyama-type congenital muscular dystrophy (FCMD). Hum Genet 103:323-327.
17. Kobayashi K, Sasaki J, Kondo-Iida E, Fukuda Y, Kinoshita M, Sunada Y, Nakamura Y, Toda T. 2001. Structural organization, complete genomic sequences, and mutational analyses of the Fukuyama-type congenital muscular dystrophy, fukutin. FEBS Lett 489:192-196.
18. Kondo-Iida E, Kobayashi K, Watanabe M, Sasaki J, Kumagai T, Koide H, Saito K, Osawa M, Nakamura Y, Toda T. 1999. Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD). Hum Mol Genet 8:2303-2309.
19. Kurahashi H, Taniguchi M, Meno C, Taniguchi Y, Takeda S, Horie M, Otani H, Toda T. 2005. Basement membrane fragility underlies embryonic lethality in fukutin-null mice. Neurobiol Dis 19:208-217.
20. McConlogue L, Brow MA, Innis MA. 1988. Structure-independent DNA amplification by PCR using 7-deaza-2′-deoxyguanosine. Nucleic Acids Res 16:9869.
21. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, Straub V, Mathews KD, Moore SA, Campbell KP. 2002. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418:417-422.
22. Nonaka I, Chou SM. 1979. Congenital muscular dystrophy. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology, Vol. 41. Amsterdam: North-Holland. pp 27-50.
23. Shen L, Wu LC, Sanlioglu S, Chen R, Mendoza AR, Dangel AW, Carroll MC, Zipf WB, Yu CY. 1994. Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and the C4B genes in the HLA class III region. Molecular cloning, exon-intron structure, composite retroposon, and breakpoint of gene duplication. J Biol Chem 269:8466-8476.
24. Silan F, Yoshioka M, Kobayashi K, Simsek E, Tune M, Alper M, Cam M, Guven A, Fukuda Y, Kinoshita M, Kocabay K, Toda T. 2003. A new mutation of the fukutin gene in a non-Japanese patient. Ann Neurol 53:392-396.
25. Toda T, Segawa M, Nomura Y, Nonaka I, Masuda K, Ishihara T, Sakai M, Tomita I, Origuchi Y, Ohno K, Misugi N, Sasaki Y, Takada K, Kawai M, Otani K, Murakami T, Saito K, Fukuyama Y, Shimizu T, Kanazawa I, Nakamura Y. 1993. Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33. Nat Genet 5:283-286.
26. Toda T, Miyake M, Kobayashi K, Mizuno K, Saito K, Osawa M, Nakamura Y, Kanazawa I, Nakagome Y, Tokunaga K, Nakahori Y. 1996. Linkage-disequilibrium mapping narrows the Fukuyama-type congenital muscular dystrophy (FCMD) candidate region to <100 kb. Am J Hum Genet 59:1313-1320.
27. Toda T, Kobayashi K, Takeda S, Sasaki J, Kurahashi H, Kano H, Tachikawa M, Wang F, Nagai Y, Taniguchi K, Taniguchi M, Sunada Y, Terashima T, Endo T, Matsumura K. 2003. Fukuyama-type congenital muscular dystrophy (FCMD) and α-dystroglycanopathy. Congenit Anom 43:97-104.
28. Wilund KR, Ming Y, Campagna F, Area M, Zuliani G, Fellin R, Ho Y, Garcia JV, Hobbs HH, Cohen JC. 2002. Molecular mechanisms of autosomal recessive hypercholesterolemia. Hum Mol Genet 11:3019-3030.
29. Yoshida A, Kobayashi K, Manya H, Taniguchi K, Kano H, Mizuno M, Inazu T, Mitsuhashi H, Takahashi S, Takeuchi M, Herrmann R, Straub V, Talin B, Voit T, Topaloglu H, Toda T, Endo T. 2001. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 1:717-724.